Characterization of Vaccine-induced Responses Against Monkeypox (MoVIHvax) An Observational Prospective Cohort Study
Recruiting · NCT05562323 · Observational (researchers observe without assigning treatment) · Lead sponsor: Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
View the official record on ClinicalTrials.gov →What this trial is about
This observational study has been designed to characterize humoral and cellular immune responses after vaccination against monkeypox (MKP) in HIV positive and negative individuals at high risk of MKP infection during the vaccination campaign in the current monkeypox outbreak.
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult individuals of ≥18 years old.
- Willing to comply with the requirements of the protocol and available for follow-up for the planned duration of the trial.
- Has understood the information provided and capable of giving informed consent.
Exclusion criteria
- \. Participant has any medical condition and/or finding that in the investigator opinion might increase participant risks, interfere with the study or impair interpretation of study data.
Where it is running
3 locations listed.
- Germans Trias i Pujol Hospital - Badalona, Barcelona, Spain
- BCN Checkpoint - Barcelona, Barcelona, Spain
- VALLE HEBRÓN HOSPITAL/Centro Salud Internacional y Enfermedades Transmisibles Drassanes - Barcelona, Barcelona, Spain